Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population
Crossref DOI link: https://doi.org/10.1186/s12978-016-0211-3
Published Online: 2016-08-22
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Law, Amy
Pilon, Dominic
Lynen, Richard
Laliberté, François
Gozalo, Laurence
Lefebvre, Patrick
Duh, Mei Sheng
Funding for this research was provided by:
Bayer HealthCare Pharmaceuticals Inc
